β-cell function prior to liver transplantation contributes to post-operative diabetes

Ichikawa,Tatsuki; Taura,Naota; Miyaaki,Hisamitsu; Miuma,Satoshi; Shibata,Hidetaka; Honda,Takuya; Hidaka,Masaaki; Soyama,Akihiko; Takatsuki,Mitsuhisa; Eguchi,Susumu; Nakao,Kazuhiko

doi:10.3892/br.2016.788

β-cell function prior to liver transplantation contributes to post-operative diabetes

Authors:
- Tatsuki Ichikawa
- Naota Taura
- Hisamitsu Miyaaki
- Satoshi Miuma
- Hidetaka Shibata
- Takuya Honda
- Masaaki Hidaka
- Akihiko Soyama
- Mitsuhisa Takatsuki
- Susumu Eguchi
- Kazuhiko Nakao
View Affiliations

Affiliations: Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852‑8501, Japan, Department of Transplantation and Digestive Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852‑8501, Japan
Published online on: October 21, 2016 https://doi.org/10.3892/br.2016.788
Pages: 749-757

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver cirrhosis and diabetes mellitus (DM) are closely associated. The present study aimed to determine whether liver transplantation (LT) may prevent/cure DM in patients with cirrhosis and whether the degree of glucose tolerance prior to transplantation is associated with the onset of DM after transplantation. Seventy‑three patients who received a living donor LT at Nagasaki University Hospital (Nagasaki, Japan) between November 2005 and December 2012 were recruited. Among them, patients were considered diabetic if they had been prescribed diabetes medications or had impaired glucose tolerance, as evidenced by an oral glucose tolerance test (OGTT). Patients were followed up until December 31, 2013 to evaluate glucose tolerance. Patients who had developed DM 2 years after transplantation were found to be older and the incidence of diabetes prior to transplantation (n=73) was higher than in those who did not. Multivariate analysis revealed that DM requiring treatment prior to transplantation was the only independent factor for DM developed at 2 years after transplantation. OGTT results showed that in patients with poor insulin sensitivity indices prior to transplantation (n=45), improvements were seen at 2 years after transplantation, while β‑cell function and insulinogenic index had decreased, which may have been the cause of DM after transplantation. In conclusion, the pre-operative β‑cell function determined by an OGTT may be a useful predictive tool for the recurrence of DM after LT.

View Figures

View References

1	Davis TME, Peters KE, Bruce DG and Davis WA: Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: The Fremantle Diabetes Study. J Clin Endocrinol Metab. 97:1581–1588. 2012. View Article : Google Scholar : PubMed/NCBI
2	El-Serag HB, Tran T and Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 126:460–468. 2004. View Article : Google Scholar : PubMed/NCBI
3	Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA and Maldonado-Garza H: Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 15:280–288. 2009. View Article : Google Scholar : PubMed/NCBI
4	Perseghin G, Mazzaferro V, Sereni LP, Regalia E, Benedini S, Bazzigaluppi E, Pulvirenti A, Leão AA, Calori G, Romito R, et al: Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation. Hepatology. 31:694–703. 2000. View Article : Google Scholar : PubMed/NCBI
5	Marchetti P: New-onset diabetes after liver transplantation: From pathogenesis to management. Liver Transpl. 11:612–620. 2005. View Article : Google Scholar : PubMed/NCBI
6	Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS and Chakkera HA: Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J. Transplant. 2012:6147812012. View Article : Google Scholar : PubMed/NCBI
7	Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG and Kudva YC: Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation. Diabet Med. 29:e1–e12. 2012. View Article : Google Scholar : PubMed/NCBI
8	Tominaga M, Makino H, Yoshino G, Kuwa K, Takei I, Aono Y, Hoshino T, Umemoto M, Shimatsu A, Sanke T, et al: Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: Comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem. 42:41–46. 2005. View Article : Google Scholar : PubMed/NCBI
9	Mari A, Pacini G, Murphy E, Ludvik B and Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 24:539–548. 2001. View Article : Google Scholar : PubMed/NCBI
10	Matsuda M and DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care. 22:1462–1470. 1999. View Article : Google Scholar : PubMed/NCBI
11	Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W and Gerich J: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 23:295–301. 2000. View Article : Google Scholar : PubMed/NCBI
12	Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
13	Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J and Laakso M: Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes. 58:1212–1221. 2009. View Article : Google Scholar : PubMed/NCBI
14	Watt KDS, Pedersen RA, Kremers WK, Heimbach JK and Charlton MR: Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study. Am J Transplant. 10:1420–1427. 2010. View Article : Google Scholar : PubMed/NCBI
15	Yoshizumi T, Shirabe K, Taketomi A, Uchiyama H, Harada N, Ijichi H, Yoshimatsu M, Ikegami T, Soejima Y and Maehara Y: Risk factors that increase mortality after living donor liver transplantation. Transplantation. 93:93–98. 2012. View Article : Google Scholar : PubMed/NCBI
16	Dare AJ, Plank LD, Phillips ARJ, Gane EJ, Harrison B, Orr D, Jiang Y and Bartlett AS: Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation. Liver Transpl. 20:281–290. 2014. View Article : Google Scholar : PubMed/NCBI
17	Zein NN, Abdulkarim AS, Wiesner RH, Egan KS and Persing DH: Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol. 32:209–217. 2000. View Article : Google Scholar : PubMed/NCBI
18	Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, Niemann CU, Shiboski S, Prasad M, Tavakol M, et al: Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl. 16:1242–1248. 2010. View Article : Google Scholar : PubMed/NCBI
19	Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, Jacobson JS, Hershman DL, Verna EC, Zaretsky J, et al: Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation. 94:539–543. 2012. View Article : Google Scholar : PubMed/NCBI
20	Defronzo RA: Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 58:773–795. 2009. View Article : Google Scholar : PubMed/NCBI
21	Henchoz E, D'Alessio DA, Gillet M, Halkic N, Matzinger O, Goy JJ, Chioléro R, Tappy L and Schneiter P: Impaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients. Transplantation. 76:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
22	Stockmann M, Konrad T, Nolting S, Hünerbein D, Wernecke KD, Döbling H, Steinmüller T and Neuhaus P: Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation. Liver Transpl. 12:535–543. 2006. View Article : Google Scholar : PubMed/NCBI
23	Watt KD, Dierkhising R, Fan C, Heimbach JK, Tillman H, Goldstein D, Thompson A, Krishnan A and Charlton MR: Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: Insight into mechanisms of disease. Am J Transplant. 13:2450–2457. 2013. View Article : Google Scholar : PubMed/NCBI
24	Ling Q, Xie H, Lu D, Wei X, Gao F, Zhou L, Xu X and Zheng S: Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population. J Hepatol. 58:271–277. 2013. View Article : Google Scholar : PubMed/NCBI
25	Johansson LE, Lindblad U, Larsson CA, Råstam L and Ridderstråle M: Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity. Eur J Endocrinol. 159:577–583. 2008. View Article : Google Scholar : PubMed/NCBI
26	Iwata M, Maeda S, Kamura Y, Takano A, Kato H, Murakami S, Higuchi K, Takahashi A, Fujita H, Hara K, et al: Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals. Diabetes Care. 35:1763–1770. 2012. View Article : Google Scholar : PubMed/NCBI
27	Ling Q, Dong F, Geng L, Liu Z, Xie H, Xu X and Zheng S: Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patients. Gene. 522:214–218. 2013. View Article : Google Scholar : PubMed/NCBI